3,4-methylenedioxyamphetamine has been researched along with Acute Kidney Failure in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woodrow, G | 1 |
| Harnden, P | 1 |
| Turney, JH | 1 |
| Barrett, PJ | 1 |
| Taylor, GT | 1 |
| Fahal, IH | 1 |
| Sallomi, DF | 1 |
| Yaqoob, M | 1 |
| Bell, GM | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Acute Kidney Failure
| Article | Year |
|---|---|
Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').
Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Pressure; Brain | 1995 |
'Ecstasy' ingestion: a case report of severe complications.
Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Amphetamine; Designer Drugs; Disseminated | 1993 |
Acute renal failure after ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Designer Drugs; Humans; Male; N-Methyl-3, | 1992 |